1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  11:35 2022-08-08 am EDT
1.218 EUR   +0.66%
08/05European ADRs Move Lower in Friday Trading
MT
08/04European ADRs Move Higher in Thursday Trading
MT
08/03European ADRs Nudge Higher in Wednesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Nudge Higher in Friday Trading

04/29/2022 | 11:03am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -5.13% 2.22 Delayed Quote.-37.60%
ASCENDIS PHARMA A/S 4.24% 98.93 Delayed Quote.-29.45%
AVADEL PHARMACEUTICALS PLC 7.31% 6.31 Delayed Quote.-27.23%
BBVA 0.55% 4.6465 Delayed Quote.-11.98%
ERYTECH PHARMA S.A. 0.66% 1.218 Real-time Quote.-42.92%
LLOYDS BANKING GROUP PLC 0.73% 45.24 Delayed Quote.-6.05%
MEREO BIOPHARMA GROUP PLC -8.53% 1.18 Delayed Quote.-19.38%
MORPHOSYS AG 0.13% 22.46 Delayed Quote.-32.74%
NATIONAL GRID PLC 1.16% 1135 Delayed Quote.5.87%
NOVO NORDISK A/S -0.79% 750 Delayed Quote.2.86%
OPERA LIMITED 1.57% 5.18 Delayed Quote.-27.76%
SMITH & NEPHEW PLC 1.45% 1086 Delayed Quote.-17.24%
TELEFÓNICA, S.A. -0.16% 4.275 Delayed Quote.11.16%
VEON LTD. -2.62% 0.4755 Delayed Quote.-71.44%
VERONA PHARMA PLC 3.73% 6.95 Delayed Quote.-0.30%
VODAFONE GROUP PLC -0.35% 121.02 Delayed Quote.8.18%
All news about ERYTECH PHARMA S.A.
08/05European ADRs Move Lower in Friday Trading
MT
08/04European ADRs Move Higher in Thursday Trading
MT
08/03European ADRs Nudge Higher in Wednesday Trading
MT
07/28European ADRs Decline in Thursday Trading
MT
07/22European ADRs Edge Higher in Friday Trading
MT
07/13European ADRs Move Higher in Wednesday Trading
MT
07/11European ADRs Move Lower in Monday Trading
MT
07/07European ADRs Move Higher in Thursday Trading
MT
07/06European ADRs Move Lower in Wednesday Trading
MT
06/30ERYTECH PHARMA S.A. : Monthly statement on outstanding equity shares and voting rights
CO
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 9,20 M 9,40 M 9,40 M
Net income 2022 -52,8 M -54,0 M -54,0 M
Net Debt 2022 1,50 M 1,53 M 1,53 M
P/E ratio 2022 -0,55x
Yield 2022 -
Capitalization 37,8 M 38,6 M 38,6 M
EV / Sales 2022 4,27x
EV / Sales 2023 2,40x
Nbr of Employees 181
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 1,22 €
Average target price 3,60 €
Spread / Average Target 196%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-42.92%38
GILEAD SCIENCES, INC.-15.87%76 626
VERTEX PHARMACEUTICALS31.16%73 868
REGENERON PHARMACEUTICALS, INC.-2.84%65 600
BIONTECH SE-28.97%44 499
WUXI APPTEC CO., LTD.-20.64%41 093